ATE79278T1 - Markierung von traegermolekuelen mit metallionen. - Google Patents

Markierung von traegermolekuelen mit metallionen.

Info

Publication number
ATE79278T1
ATE79278T1 AT87301869T AT87301869T ATE79278T1 AT E79278 T1 ATE79278 T1 AT E79278T1 AT 87301869 T AT87301869 T AT 87301869T AT 87301869 T AT87301869 T AT 87301869T AT E79278 T1 ATE79278 T1 AT E79278T1
Authority
AT
Austria
Prior art keywords
labeling
metal ions
carrier molecules
metal ion
dihydroxyl
Prior art date
Application number
AT87301869T
Other languages
English (en)
Inventor
Robert A Nicolotti
Alan R Ketring
Koon Y Pak
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE79278T1 publication Critical patent/ATE79278T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87301869T 1986-03-05 1987-03-04 Markierung von traegermolekuelen mit metallionen. ATE79278T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/836,535 US4732974A (en) 1986-03-05 1986-03-05 Metal ion labeling of carrier molecules
EP87301869A EP0248506B1 (de) 1986-03-05 1987-03-04 Markierung von Trägermolekülen mit Metallionen

Publications (1)

Publication Number Publication Date
ATE79278T1 true ATE79278T1 (de) 1992-08-15

Family

ID=25272173

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87301869T ATE79278T1 (de) 1986-03-05 1987-03-04 Markierung von traegermolekuelen mit metallionen.

Country Status (8)

Country Link
US (1) US4732974A (de)
EP (1) EP0248506B1 (de)
JP (1) JPH0791317B2 (de)
AT (1) ATE79278T1 (de)
AU (1) AU596828B2 (de)
CA (1) CA1288197C (de)
DE (1) DE3781031T2 (de)
ES (1) ES2035041T3 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830847A (en) * 1985-06-28 1989-05-16 The Procter & Gamble Company Diphosphonate-derivatized macromolecules
US5082930A (en) * 1986-05-29 1992-01-21 Mallinckrodt Medical, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
US4952393A (en) * 1987-04-02 1990-08-28 The General Hospital Corporation Organ infarct imaging with technetium labelled glucarate
US5177192A (en) * 1987-04-02 1993-01-05 Centocor, Incorporated Method for labeling antibodies with a metal ion
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
US5648471A (en) * 1987-12-03 1997-07-15 Centocor, Inc. One vial method for labeling antibodies with Technetium-99m
US5059541A (en) * 1988-04-29 1991-10-22 Neorx Corporation Minimal derivatization of proteins
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US4946668A (en) * 1988-10-07 1990-08-07 Centocor, Inc. Tumor imaging with technetium labelled glucarate
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
GR1002475B (el) * 1988-12-05 1996-11-26 Novartis Ag (Novartis Sa) (Novartis Inc.) Μεθοδος παρασκευης πεπτιδικων παραγωγων.
EP0593452A1 (de) * 1989-11-30 1994-04-27 Mallinckrodt Medical, Inc. Verfahren zur herstellung eines mit metallradionuklid markierten proteins
US5130129A (en) * 1990-03-06 1992-07-14 The Regents Of The University Of California Method for enhancing antibody transport through capillary barriers
WO1992005802A1 (en) * 1990-09-28 1992-04-16 Neorx Corporation Polymeric carriers for release of covalently linked agents
WO1992011039A1 (en) * 1990-12-17 1992-07-09 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Derivatized tris-catechol chelating agents
US5645815A (en) 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
AU658403B2 (en) * 1991-02-27 1995-04-13 Akzo N.V. Technetium-99m labeling of proteins
JPH06509102A (ja) * 1991-07-01 1994-10-13 マリンクロッド・メディカル・インコーポレイテッド 体内造影抗イディオタイプ抗体を用いた組織特異的造影剤
US5326856A (en) * 1992-04-09 1994-07-05 Cytogen Corporation Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
US5346686A (en) * 1992-10-05 1994-09-13 Mallinckrodt Medical, Inc. Labelled interleukin-8 and medical uses thereof
US5605671A (en) * 1992-10-05 1997-02-25 The Regents Of The University Of Michigan Radiolabeled neutrophil activating peptides for imaging
US5413778A (en) * 1992-10-05 1995-05-09 The Regents Of The University Of Michigan Labelled monocyte chemoattractant protein material and medical uses thereof
WO1994009128A1 (en) * 1992-10-22 1994-04-28 Mallinckrodt Medical, Inc. Therapeutic treatment for inhibiting vascular restenosis
CA2154667A1 (en) * 1993-02-02 1994-08-18 Linda M. Gustavson Directed biodistribution of small molecules
US6203775B1 (en) * 1993-03-19 2001-03-20 The General Hospital Corporation Chelating polymers for labeling of proteins
WO1994025488A1 (en) * 1993-05-03 1994-11-10 Mallinckrodt Medical, Inc. Method for preparing a metal-radionuclide-labelled protein
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms
US20030031627A1 (en) * 2001-07-31 2003-02-13 Mallinckrodt Inc. Internal image antibodies for optical imaging and therapy
TW593919B (en) * 2002-05-31 2004-06-21 Matsushita Refrigeration Vacuum heat insulating material and method for producing the same, and refrigerator using the vacuum heat insulating material
CN119456224B (zh) * 2024-10-31 2025-11-28 郑州大学 一种矿物的预处理方法协同浮选药剂的分离工艺

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2334107A1 (fr) * 1975-12-05 1977-07-01 Pasteur Institut Procede de couplage de substances biologiques par des liaisons covalentes
SE428332B (sv) * 1979-03-08 1983-06-20 Wallac Oy Forfarande for fluorescensspektroskopisk bestemning av biologiskt aktivt emne, sasom hapten, antikropp eller antigen
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4421735A (en) * 1980-04-17 1983-12-20 The Massachusetts General Hospital Radiolabeled diagnostic compositions and method for making the same
SE8006102L (sv) * 1980-09-02 1982-03-03 Gambro Ab Sett att utvinna en peptidinnehallande forening samt medel for genomforande av settet
ES516797A0 (es) * 1981-10-27 1984-05-16 Hybritech Inc Un procedimiento para preparar un anticuerpo monoclonal para un antigeno asociado a un tumor.
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
US5238808A (en) * 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
US4569794A (en) * 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process

Also Published As

Publication number Publication date
EP0248506B1 (de) 1992-08-12
JPH0791317B2 (ja) 1995-10-04
AU6970187A (en) 1987-09-10
DE3781031D1 (de) 1992-09-17
AU596828B2 (en) 1990-05-17
JPS62270600A (ja) 1987-11-24
CA1288197C (en) 1991-08-27
ES2035041T3 (es) 1993-04-16
EP0248506A1 (de) 1987-12-09
DE3781031T2 (de) 1992-12-17
US4732974A (en) 1988-03-22

Similar Documents

Publication Publication Date Title
ATE79278T1 (de) Markierung von traegermolekuelen mit metallionen.
EP0336678A3 (en) Method for radiolabeling proteins
ATE70455T1 (de) Verfahren zur reinigung von serumalbumin.
EP0452858A3 (en) Metal complexes of acid adducts to dioxime ligands useful in labelling proteins and other amine-containing compounds
DE3588226D1 (de) Kontrollierte Oxidation von mikrobiell herstellten, Cystein-enthaltenden Proteinen
DE69024376D1 (de) Verwendung von Kupfer-Komplexen von alpha-Aminsäuren mit terminalen Amino-Gruppen als Nahrungsmittelzusatz
EP0641803A3 (de) Modifizierte Polydextrose.
EP0383234A3 (de) Pasteurisiertes, gereinigtes von Willebrand-Faktor-Konzentrat und Verfahren zu seiner Herstellung
ATE57694T1 (de) Verfahren zur herstellung von 2,5dicetopiperazinen.
EP0155786A3 (en) New peptide, and production and use thereof
DK543087D0 (da) Fremgangsmaade til fremstilling af 2,6-di-tert.butyl-4-mercaptophenol samt fremgangsmaade til fremstilling af derved anvendeligt mellemprodukt
PT86233A (fr) Procede de preparation d:une variant de l:hirudine
AU4629885A (en) 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
ATE49214T1 (de) Platinkomplexe von aliphatischen tricarbonsaeuren.
GB1492252A (en) Determination of antipyrine
PL238572A1 (en) Pesticide and method of manufacture of novel substituted diamides of hydroxymalonic acids
ATE130009T1 (de) Antitumor-aminosäuren und peptid-derivate von 1,4-bis((aminoalkyl und hydroxyaminoalkyl)amino>5,8- dihydroxyanthraquinonen.
DE69018375D1 (de) Pro-drugs von 6-Mercaptopurin und 6-Thioguanin.
NO178325C (no) Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat
DK162095C (da) Fremgangsmaade til fremstilling af thiotetronsyre
PL151373B2 (de)
JPS5522691A (en) Manufacture of r*ss55pphydroxyphenyll2*44 imidazolidione or r*ss55pphydroxyphenylhydantoin
DE3669263D1 (de) Stabilisierung von interferonen.
DK172289A (da) Fremgangsmaade til fremstilling af 3-amino-2,2,4,4-tetramethylthietan ved leuckardt-reaktionen
ATE16279T1 (de) Verfahren zur gewinnung von d,l-homocystin.